{
    "Trade/Device Name(s)": [
        "BreathID Hp Lab System",
        "BreathID Smart System"
    ],
    "Submitter Information": "Meridian Bioscience Israel Ltd.",
    "510(k) Number": "K220494",
    "Predicate Device Reference 510(k) Number(s)": [
        "K173777",
        "K193610"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "MSQ",
        "JJQ"
    ],
    "Summary Letter Date": "June 23, 2022",
    "Summary Letter Received Date": "February 22, 2022",
    "Submission Date": "June 10, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.3110"
    ],
    "Regulation Name(s)": [
        "Campylobacter Fetus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "13CO2/12CO2 ratio",
        "Helicobacter pylori urease activity"
    ],
    "Specimen Type(s)": [
        "Exhaled breath"
    ],
    "Specimen Container(s)": [
        "Breath sample bag"
    ],
    "Instrument(s)/Platform(s)": [
        "BreathID Hp device",
        "Auto Sampler",
        "Lab Application",
        "BreathID Smart device"
    ],
    "Method(s)/Technology(ies)": [
        "Molecular Correlation Spectroscopy (MCS)",
        "Electro-optical measurement"
    ],
    "Methodologies": [
        "Optical absorption measurement",
        "Breath test"
    ],
    "Submission Type(s)": [
        "System",
        "Kit",
        "Device",
        "Software",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for BreathID Hp Lab and BreathID Smart non-invasive breath test systems for H. pylori detection using 13C-urea breath analysis.",
    "Indications for Use Summary": "Intended for non-invasive measurement of exhaled 13CO2/12CO2 ratio to aid in initial diagnosis and post-treatment monitoring of H. pylori infection in adults and pediatric patients (ages 3-17).",
    "fda_folder": "Microbiology"
}